Larimar Therapeutics Reports Third Quarter 2025 Financial Results
Go back to Larimar Therapeutics Reports Third Quarter 2025 Financial Results| (NASDAQ: LRMR) | Delayed: 4.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.32 | 52 Week High | $ | |||
| Open | $4.32 | 52 Week Low | $ | |||
| Day High | $4.32 | P/E | N/A | |||
| Day Low | $4.32 | EPS | $ | |||
| Volume | 4 | |||||

